Tag: AF Symposium 2021
AF Symposium 2021: HARTCAP-AF supports hybrid over catheter ablation
Hybrid ablation, a procedure which involves “attacking” the atrial substrate from the epicardium and endocardium, has been shown to result in significantly higher freedom...
AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF
Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...
AF Symposium 2021: Hybrid, multidisciplinary therapy superior to catheter ablation for...
Results of a sub-analysis of the CONVERGE clinical trial, presented during a late-breaking trial session at the digital AF Symposium (29–31 January, virtual), suggest...
Medtronic receives FDA approval for DiamondTemp ablation system
Medtronic has received US Food and Drug Administration (FDA) approval for the DiamondTemp ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial...
AF Symposium 2021: Live case from ECLIPSE-AF study to feature
Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac arrhythmias, has announced that the proprietary Centauri system will...
AF Symposium 2021: Early results of CathVision Cube to be announced
CathVision ApS has announced that its novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, will be...
AF Symposium 2021: Two cases highlight Acutus’ mapping technology
Acutus Medical has announced a number presentations relating to its mapping and ablation procedures during 26th Annual International AF Symposium (29–31 January, virtual). The...